Article Information
Volume 77, Issue 6, pp. 1322-1330
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 25, 2016
- Revision received November 10, 2016
- Accepted December 5, 2016
- Published first December 28, 2016.
Article Versions
- Previous version (December 28, 2016 - 06:04).
- Previous version (March 2, 2017 - 07:46).
- You are viewing the most recent version of this article.
Copyright & Usage
©2016 American Association for Cancer Research.
Author Information
- David Y. Oh1,
- Jason Cham1,
- Li Zhang1,
- Grant Fong1,
- Serena S. Kwek1,
- Mark Klinger2,
- Malek Faham2, and
- Lawrence Fong1,*
- 1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
- 2Adaptive Biotechnologies, South San Francisco, California.
- ↵*Corresponding Author:
Lawrence Fong, University of California San Francisco, 513 Parnassus Avenue, Room HSE301A, Box 0519, San Francisco, CA 94143-0519. Phone: 415-514-3160; Fax: 415-476-0459; E-mail: lfong{at}medicine.ucsf.edu
D.Y. Oh and J. Cham contributed equally to this article.
March 2017
Volume 77, Issue 6
Volume 77, Issue 6
Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire
Permalink:
Jump to section
Advertisement